Camellino, Dario http://orcid.org/0000-0001-6384-6458
Giusti, Andrea
Girasole, Giuseppe
Bianchi, Gerolamo
Dejaco, Christian
Article History
First Online: 6 September 2019
Compliance with Ethical Standards
:
: No sources of funding or writing assistance were received for the preparation of this article.
: Dario Camellino has received consultancy and speaker fees from AbbVie, Celgene, Janssen-Cilag, Lilly, Mylan and Sanofi; none related to this article. Andrea Giusti has received consultancy and speaker fees from Abiogen, Amgen, EffRx, Eli Lilly, Internis, Labatec, NewBridge, PharmaLink and UCB; none related to this article. Giuseppe Girasole has received speaker fees from Abiogen; none related to this article. Gerolamo Bianchi has received honoraria and/or consulting fees from Abbvie, Abiogen, Alfa-Sigma, Amgen, BMS, Celgene, Chiesi, Eli Lilly, GSK, Janssen, Medac, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Sanofi Genzyme and Servier. Christian Dejaco has received consultancy fees and honoraria from AbbVie, Celgene, Eli Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Sandoz and UCB and unrestricted grant support from Celgene.